{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:42:13Z","timestamp":1777383733191,"version":"3.51.4"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["17441903000"],"award-info":[{"award-number":["17441903000"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008410","name":"Shanghai Municipal Population and Family Planning Commission","doi-asserted-by":"publisher","award":["20174Y0125"],"award-info":[{"award-number":["20174Y0125"]}],"id":[{"id":"10.13039\/501100008410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background and Purpose:<\/jats:bold> There are many benefits of administering dexmedetomidine perioperatively. The pharmacokinetics (PK) and pharmacodynamics (PD) of intravenous, intranasal and oral dexmedetomidine that was administered before anesthesia were compared in this study, and the effects of dexmedetomidine on the surgical field visibility in tympanoplasty was evaluated.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> A single-blind, randomized controlled trial was conducted in a university-affiliated hospital where 45 patients who underwent tympanoplasty under general anesthesia were randomly allocated into three groups. Dexmedetomidine was administered by intravenous infusion at 0.8\u00a0\u03bcg.kg<jats:sup>\u22121<\/jats:sup> for 10\u00a0min, intranasal instillation at a drop rate of 1\u00a0\u03bcg.kg<jats:sup>\u22121<\/jats:sup> and oral intake at 4\u00a0\u03bcg.kg<jats:sup>\u22121<\/jats:sup> ten minutes before the induction of anesthesia. The PK and PD of dexmedetomidine after a single low dose administration and its effect on the surgical field in tympanoplasty were analysed.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> A plasma concentration of dexmedetomidine of 220\u00a0pg\/ml was achieved immediately after intravenous infusion and at 13.2 and 70.3\u00a0min for intranasal and oral administration, respectively. Dexmedetomidine decreased the heart rate (HR) and mean arterial pressure (MAP) in all three groups, although these values remained higher in the oral dexmedetomidine group at all eight time points. Intravenous dexmedetomidine provided the best visualization of the surgical field for opening of the tympanic sinus, 30\u00a0min after the start of the infusion (<jats:italic>p<\/jats:italic> &amp;lt; 0.05). Intranasal dexmedetomidine provided a significantly better visual field than oral dexmedetomidine for the repair of a tympanic membrane perforation using the fascia temporal muscle (<jats:italic>p<\/jats:italic> &amp;lt; 0.05).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> A single low dose of dexmedetomidine administered intravenously or intranasally could decrease HR and MAP, improve surgical field visibility and be appropriate for deliberate hypotension for surgical procedures of 1\u20132\u00a0h in length.<\/jats:p><jats:p><jats:bold>Trial registration:<\/jats:bold> Clinicaltrials.gov identifier: NCT03800641.<\/jats:p>","DOI":"10.3389\/fphar.2022.760916","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T05:06:41Z","timestamp":1644296801000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Perioperative Low Dose Dexmedetomidine and Its Effect on the Visibility of the Surgical Field for Middle Ear Microsurgery: A Randomised Controlled Trial"],"prefix":"10.3389","volume":"13","author":[{"given":"Jinhong","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji\u2019e","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1046\/j.1365-2125.2003.01944.x","article-title":"Bioavailability of Dexmedetomidine after Extravascular Doses in Healthy Subjects","volume":"56","author":"Anttila","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/BF03015479","article-title":"Comparison of Sodium Nitroprusside- and Esmolol-Induced Controlled Hypotension for Functional Endoscopic Sinus Surgery","volume":"42","author":"Boezaart","year":"1995","journal-title":"Can. J. Anaesth."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1097\/ALN.0000000000003568","article-title":"A Pharmacokinetic and Pharmacodynamic Study of Oral Dexmedetomidine","volume":"133","author":"Chamadia","year":"2020","journal-title":"Anesthesiology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","article-title":"SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials","volume":"158","author":"Chan","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/bja\/aex086","article-title":"Dexmedetomidine Pharmacodynamics in Healthy Volunteers: 2. Haemodynamic Profile","volume":"119","author":"Colin","year":"2017","journal-title":"Br. J. Anaesth."},{"key":"B6","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/00000542-200008000-00016","article-title":"The Effects of Increasing Plasma Concentrations of Dexmedetomidine in Humans","volume":"93","author":"Ebert","year":"2000","journal-title":"Anesthesiology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/2052-0492-1-15","article-title":"A Comparison between Dosages and Plasma Concentrations of Dexmedetomidine in Clinically Ill Patients: a Prospective, Observational, Cohort Study in Japan","volume":"1","author":"Fujita","year":"2013","journal-title":"J. Intensive Care"},{"key":"B8","doi-asserted-by":"publisher","first-page":"375","DOI":"10.4103\/joacp.JOACP_350_15","article-title":"Evaluation of the Efficacy of Desflurane with or without Labetalol for Hypotensive Anesthesia in Middle Ear Microsurgery","volume":"33","author":"Gupta","year":"2017","journal-title":"J. Anaesthesiol Clin. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00228-011-1002-y","article-title":"Bioavailability of Dexmedetomidine after Intranasal Administration","volume":"67","author":"Iirola","year":"2011","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"668285","DOI":"10.3389\/fphar.2021.668285","article-title":"D-amphetamine Rapidly Reverses Dexmedetomidine-Induced Unconsciousness in Rats","volume":"12","author":"Kato","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.bja.2017.11.100","article-title":"Pharmacokinetic and Pharmacodynamic Study of Intranasal and Intravenous Dexmedetomidine","volume":"120","author":"Li","year":"2018","journal-title":"Br. J. Anaesth."},{"key":"B12","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/anae.13407","article-title":"A Comparison of Intranasal Dexmedetomidine for Sedation in Children Administered Either by Atomiser or by Drops","volume":"71","author":"Li","year":"2016","journal-title":"Anaesthesia"},{"key":"B13","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1097\/MAO.0000000000000996","article-title":"Effects of a Single Dose Dexmedetomidine on Surgical Field Visibility during Middle Ear Microsurgery: A Randomized Study","volume":"37","author":"Liu","year":"2016","journal-title":"Otol. Neurotol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.bja.2018.01.035","article-title":"Does Intranasal Dexmedetomidine Provide Adequate Plasma Concentrations for Sedation in Children: a Pharmacokinetic Study","volume":"120","author":"Miller","year":"2018","journal-title":"Br. J. Anaesth."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e20153845","DOI":"10.1542\/peds.2015-3845","article-title":"Iatrogenic Cushing's Syndrome Due to Intranasal Usage of Ophthalmic Dexamethasone: A Case Report","volume":"137","author":"Orton","year":"2016","journal-title":"Pediatrics"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1007\/s12630-019-01440-6","article-title":"Perioperative Dexmedetomidine Reduces Delirium in Elderly Patients after Non-cardiac Surgery: a Systematic Review and Meta-Analysis of Randomized-Controlled Trials","volume":"66","author":"Pan","year":"2019","journal-title":"Can. J. Anaesth."},{"key":"B17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.bja.2021.03.040","article-title":"Perioperative Dexmedetomidine and 5-year Survival in Patients Undergoing Cardiac Surgery","volume":"127","author":"Peng","year":"2021","journal-title":"Br. J. Anaesth."},{"key":"B18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/EJA.0000000000001131","article-title":"Dexmedetomidine versus Propofol Sedation in Reducing Delirium Among Older Adults in the ICU: A Systematic Review and Meta-Analysis","volume":"37","author":"Pereira","year":"2020","journal-title":"Eur. J. Anaesthesiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4193\/Rhin15.085","article-title":"Intranasal Atomised Dexmedetomidine Optimises Surgical Field Visualisation with Decreased Blood Loss during Endoscopic Sinus Surgery: a Randomized Study","volume":"54","author":"Qiao","year":"2016","journal-title":"Rhinology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/EJA.0000000000001113","article-title":"Preventive Effect of Dexmedetomidine on Postictal Delirium after Electroconvulsive Therapy: A Randomised Controlled Study","volume":"37","author":"Qiu","year":"2020","journal-title":"Eur. J. Anaesthesiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1177\/00912700122012832","article-title":"The Single-Dose Pharmacokinetics of Midazolam and its Primary Metabolite in Pediatric Patients after Oral and Intravenous Administration","volume":"41","author":"Reed","year":"2001","journal-title":"J. Clin. Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/bcp.13163","article-title":"Pharmacokinetics and Pharmacodynamics of a New Highly Concentrated Intranasal Midazolam Formulation for Conscious Sedation","volume":"83","author":"Schrier","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"key":"B24","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1017\/S0022215115001334","article-title":"Dexmedetomidine Improves the Quality of the Operative Field for Functional Endoscopic Sinus Surgery: Systematic Review","volume":"129","author":"Snidvongs","year":"2015","journal-title":"J. Laryngol. Otol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1001\/jama.2019.0234","article-title":"Effect of Intravenous Acetaminophen vs Placebo Combined with Propofol or Dexmedetomidine on Postoperative Delirium Among Older Patients Following Cardiac Surgery: The DEXACET Randomized Clinical Trial","volume":"321","author":"Subramaniam","year":"2019","journal-title":"JAMA"},{"key":"B26","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s40262-017-0507-7","article-title":"Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine","volume":"56","author":"Weerink","year":"2017","journal-title":"Clin. Pharmacokinet."},{"key":"B27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12871-019-0759-x","article-title":"Comparison of Surgical Field Visibility during Propofol or Desflurane Anesthesia for Middle Ear Microsurgery","volume":"19","author":"Yuan","year":"2019","journal-title":"BMC Anesthesiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1213\/01.ane.0000269488.06546.7c","article-title":"A Double-Blind, Crossover Assessment of the Sedative and Analgesic Effects of Intranasal Dexmedetomidine","volume":"105","author":"Yuen","year":"2007","journal-title":"Anesth. Analg."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.760916\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T05:06:44Z","timestamp":1644296804000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.760916\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,8]]},"references-count":28,"alternative-id":["10.3389\/fphar.2022.760916"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.760916","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,8]]},"article-number":"760916"}}